跳至主要内容
临床试验/ACTRN12613001194752
ACTRN12613001194752尚未招募4 期

A Pilot, Randomised, Blinded, Feasibility, Safety and Biochemical and Physiological Efficacy Study of Terlipressin vs. Placebo in Cardiac Surgery Patients with the Post-operative High Cardiac Output and Hypotension syndrome

Austin Health0 个研究点目标入组 40 人开始时间: 2013年10月30日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
Austin Health
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients aged 18 years or older
  • - Admitted to the intensive care unit after cardiopulmonary bypass
  • - High cardiac index (greater than 3 litres/minute/m2)
  • - Hypotension (systolic blood pressure less than 90 mmHg or mean arterial blood pressure less than 65 mmHg)

排除标准

  • - Pregnancty
  • - Death is considered imminent (within 24 hours)
  • - Known sever peripheral vascular disease
  • - Raynaud's phenomenon
  • - Known allergy to terlipressin
  • - Unstable angina
  • - Recent myocardial infarction
  • - Surgery for coronary artery disease

研究者

发起方
Austin Health

相似试验